Skip to main content

Cellbricks Therapeutics

Berlin, Germany

Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.

$8.1M raised
Mar 2026
Seed

Top Investors

VU Venture PartnersACT Venture PartnersSPRIN-DSilicon Roundabout Venturesb.value AG

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cellbricks Therapeutics

How much funding has Cellbricks Therapeutics raised?
Cellbricks Therapeutics has raised $8.1M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Who are Cellbricks Therapeutics's investors?
Cellbricks Therapeutics's investors include VU Venture Partners, ACT Venture Partners, SPRIN-D, Silicon Roundabout Ventures, b.value AG.
Where is Cellbricks Therapeutics headquartered?
Cellbricks Therapeutics is headquartered in Berlin, Germany.
What does Cellbricks Therapeutics do?
Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.
What stage is Cellbricks Therapeutics at?
Cellbricks Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cellbricks Therapeutics — Funding & Investors." VCBacked, March 25, 2026, https://www.vcbacked.co/company/cellbricks-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2026). Cellbricks Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/cellbricks-therapeutics
Wikipedia (cite web)
{{cite web |title=Cellbricks Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cellbricks-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .